LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global gene therapy for inherited genetic disorders market is
expected to post a CAGR of about 189% during the period 2019-2023,
according to the latest market research report by Technavio.
A key factor driving the global gene therapy for inherited genetic
disorders market growth is the high efficacy and safety of gene
therapies. This technology has the potential of curing inherited
diseases that are treatable but not curable with other conventional
drugs. Gene therapies are gaining momentum in clinical trials and
showing promising results with optimum efficacy and safety to treat
inherited genetic disorders. Market players are introducing gene therapy
solutions for inherited genetic disorders such as spinal muscular
atrophy and ADA-severe combined immunodeficiency. The high efficacy and
safety offered by modern gene therapies will boost the gene therapy for
inherited genetic disorders market during the forecast period.
As per Technavio’s gene therapy for inherited genetic disorders market
analysis, the increase in strategic alliances will have a positive
impact on the market and contribute to its growth significantly over the
forecast period. This global
gene therapy for inherited genetic disorders market 2019-2023 research
report also analyzes other important trends and market drivers that will
affect market growth over 2019-2023.
Global gene therapy for inherited genetic
disorders market: Increase in strategic alliances
Several vendors are entering the market to form strategic alliances with
medium enterprises and conglomerate companies. Furthermore, the
manufacture of high-quality plasmid and viral vectors is one of the
critical components required for the commercialization of cell and gene
therapy. As a result, various market players are increasingly engaging
in forming strategic collaborations to focus on developing novel
approaches for the treatment of several inherited genetic disorders.
“Market players are focusing on extensive collaborations to develop
long-term treatment therapies for patients with cystic fibrosis. Also,
market participants are also engaging in strategic partnerships to
manufacture platforms for future gene therapy programs, including the
limb-girdle muscular dystrophy. Such developments and collaborations
will lead to the growth of the market,” says a senior research
analyst at Technavio.
Global gene therapy for inherited genetic
disorders market: Segmentation analysis
This gene therapy for inherited genetic disorders market outlook
segments the global gene therapy for inherited genetic disorders market
by application (eye-disorders, hematological disorders, central nervous
system disorders, muscular disorders, and others) and geographic regions
(North America, Europe, Asia, and ROW).
North America led the market in 2018, followed by Europe, Asia, and ROW,
respectively. The market growth in North America can be attributed to
the growing prevalence of inherited genetic disorders, including sickle
cell anemia and spinal muscular atrophy in the US.
Looking for more information on this market? Request
a free sample report
Technavio’s sample reports are free of charge and contain multiple
sections of the report, such as the market size and forecast, drivers,
challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team
at media@technavio.com.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com